Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 34 citing articles:

Obesity: A Review of Pathophysiology and Classification
Bradley Busebee, Wissam Ghusn, Lizeth Cifuentes, et al.
Mayo Clinic Proceedings (2023) Vol. 98, Iss. 12, pp. 1842-1857
Open Access | Times Cited: 41
Effects of dietary fibre on metabolic health and obesity
Edward C. Deehan, Valentin Mocanu, Karen Madsen
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 301-318
Closed Access | Times Cited: 23
Type-2 diabetes mellitus remission prediction models after Roux-En-Y gastric bypass and sleeve gastrectomy based on disease severity scores
Wissam Ghusn, Karl Hage, Robert A. Vierkant, et al.
Diabetes Research and Clinical Practice (2024) Vol. 208, pp. 111091-111091
Closed Access | Times Cited: 13
Phenotyping the obesities: reality or utopia?
Piero Portincasa, Gema Frühbeck
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 767-773
Open Access | Times Cited: 19
Precision gestational diabetes treatment: a systematic review and meta-analyses
Jamie L. Benham, Véronique Gingras, Niamh‐Maire Mclennan, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 17
Precision medicine of obesity as an integral part of type 2 diabetes management – past, present, and future
Łukasz Szczerbiński, José C. Florez
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 11, pp. 861-878
Closed Access | Times Cited: 16
The association between microvascular and macrovascular diseases and diabetes remission after bariatric surgery
Wissam Ghusn, Marita Salame, Lea N. Sayegh, et al.
Surgical Endoscopy (2024) Vol. 38, Iss. 4, pp. 1835-1843
Closed Access | Times Cited: 7
Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
Wissam Ghusn, Maria D. Hurtado
Obesity Pillars (2024) Vol. 12, pp. 100127-100127
Open Access | Times Cited: 7
The role of diabetes severity scores in predicting disease remission in patients with BMI > 50 kg/m2 undergoing Roux-En-Y gastric bypass and sleeve gastrectomy: a multi-centered study
Wissam Ghusn, Pearl Ma, Kayla Ikemiya, et al.
Surgical Endoscopy (2023) Vol. 37, Iss. 9, pp. 7114-7120
Closed Access | Times Cited: 15
The melanocortin‐4 receptor pathway and the emergence of precision medicine in obesity management
Sima Fansa, Andrés Acosta
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S2, pp. 46-63
Closed Access | Times Cited: 5
TIGAR exacerbates obesity by triggering LRRK2-mediated defects in macroautophagy and chaperone-mediated autophagy in adipocytes
Tian Zhang, Ke‐Gang Linghu, Jia Tan, et al.
Autophagy (2024) Vol. 20, Iss. 8, pp. 1741-1761
Closed Access | Times Cited: 4
Appropriate use of the fixed-dose, extended-release combination of naltrexone and bupropion as treatment for obesity in primary care
Ethan Lazarus
Obesity Pillars (2025) Vol. 14, pp. 100170-100170
Open Access
The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
Iskandar Idris, Oluwaseun Anyiam
Diabetes Obesity and Metabolism (2025)
Open Access
Evolving Concepts in Cardiometabolic Risk: A Review of Recent Evidence
Omar Elsaka
Research in Cardiovascular Medicine (2025) Vol. 14, Iss. 1, pp. 15-25
Open Access
Polymorphisms of Fat Mass and Obesity-Associated Gene in the Pathogenesis of Child and Adolescent Metabolic Syndrome
Yongyan Song, Henry Wade, Bingrui Zhang, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2643-2643
Open Access | Times Cited: 10
Weight loss outcomes with semaglutide based on diabetes severity using the individualized metabolic surgery score
Wissam Ghusn, Diego Añazco, Sima Fansa, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102625-102625
Open Access | Times Cited: 3
The Impact of Artificial Sweeteners on Human Health and Cancer Association: A Comprehensive Clinical Review
Wissam Ghusn, Roopa Naik, Marcel Yibrin
Cureus (2023)
Open Access | Times Cited: 8
Cumulative effect of obesity phenotypes on body weight and body mass index
Wissam Ghusn, Lizeth Cifuentes, Diego Añazco, et al.
International Journal of Obesity (2024) Vol. 48, Iss. 6, pp. 884-890
Closed Access | Times Cited: 2
The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes
Wissam Ghusn, Sima Fansa, Diego Añazco, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2167-2175
Closed Access | Times Cited: 2
Precision Medicine in Bariatric Procedures
Khushboo Gala, Wissam Ghusn, Andrés Acosta
Gastrointestinal Endoscopy Clinics of North America (2024) Vol. 34, Iss. 4, pp. 765-779
Closed Access | Times Cited: 2
The use of semaglutide in patients with renal failure- a retrospective cohort study
Jane J. Long, Sukhdeep Sahi, Adley Lemke, et al.
Endocrine Practice (2024) Vol. 30, Iss. 10, pp. 963-969
Closed Access | Times Cited: 2
Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy
Diego Añazco, Andrés Acosta
International Journal of Obesity (2024)
Closed Access | Times Cited: 1
Long-term Hair Cortisone and Perceived Stress are Associated with Long-term Hedonic Eating Tendencies in Patients with Obesity
Susanne Kuckuck, Eline S. van der Valk, Robin Lengton, et al.
Psychoneuroendocrinology (2024) Vol. 171, pp. 107224-107224
Open Access | Times Cited: 1
Comparative effectiveness of Roux‐en‐Y gastric bypass and sleeve gastrectomy in achieving diabetes remission in patients with diabetes‐related vascular diseases: A multicentred study
Wissam Ghusn, Pearl Ma, Kayla Ikemiya, et al.
Clinical Obesity (2024)
Closed Access | Times Cited: 1
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
C. Allard, Daniela Cota, Carmelo Quarta
Drugs (2023) Vol. 84, Iss. 2, pp. 127-148
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top